prediction_file,target_file,field_name,evaluation_method,tp,fp,fn,tn,expected,actual
sobs89-975.grobid-tei.xml,sobs89-975.nxml,abstract,soft,0,1,0,0,weevaluated35casesofamechanicalapproachtoabdominalwallliftingusedinofficebasedgaslesslaparoscopicsterilizationunderlocalanesthesialiftingoftheabdominalwallusingthecameratrocarasananchoringdeviceandcomplementedbysuprapubicliftingbymeansofatowelclampledtopassiveintraabdominalairfillinggivingsufficientspacetoidentifyanesthetizecoagulateandcutthefallopiantubesonlymildsedationwasnecessaryallwomenwalkedtoandfromtheoperatingroomallhadsuccessfultuballigationtheoverallsatisfactionratewas97%themechanicalliftingmomentwasnotpainfulwiththeexceptionofonewomanwithfailedtubalanesthesiaallwomenhadalowmeanpainscoreof26vas010nocomplicationsoccurredexceptonewoundinfectionthecostswere<¼ofthoseoftraditionallaparoscopicsterilizationandofficehysteroscopicsterilizationthisapproachiseffectiveforofficebasedlaparoscopicsterilizationroomairtwostringsandaneedlereplaceactivegasinsufflationandnarcosis,weevaluated35casesofamechanicalapproachtoabdominalwallliftingusedinofficebasedgaslesslaparoscopicsterilizationunderlocalanesthesialiftingoftheabdominalwallusingthecameratrocarasananchoringdeviceandcomplementedbysuprapubicliftingbymeansofatowelclampledtopassiveintraabdominalairfillinggivingsufficientspacetoidentifyanesthetizecoagulateandcutthefallopiantubesonlymildsedationwasnecessaryallwomenwalkedtoandfromtheoperatingroomallhadsuccessfultuballigationtheoverallsatisfactionratewas97%themechanicalliftingmomentwasnotpainfulwiththeexceptionofonewomanwithfailedtubalanesthesiaallwomenhadalowmeanpainscoreof26vas010nocomplicationsoccurredexceptonewoundinfectionthecostswere£14ofthoseoftraditionallaparoscopicsterilizationandofficehysteroscopicsterilizationthisapproachiseffectiveforofficebasedlaparoscopicsterilizationroomairtwostringsandaneedlereplaceactivegasinsufflationandnarcosis
sobs89-975.grobid-tei.xml,sobs89-975.nxml,abstract,exact,0,1,0,0,"we evaluated 35 cases of a mechanical approach to abdominal wall lifting, used in office-based gasless laparoscopic sterilization under local anesthesia. lifting of the abdominal wall, using the camera trocar as an anchoring device and complemented by suprapubic lifting by means of a towel clamp, led to passive intra-abdominal air filling, giving sufficient space to identify, anesthetize, coagulate and cut the fallopian tubes. only mild sedation was necessary. all women walked to and from the operating room. all had successful tubal ligation. the overall satisfaction rate was 97%. the mechanical lifting moment was not painful. with the exception of one woman with failed tubal anesthesia, all women had a low mean pain score of 2.6 (vas 0–10). no complications occurred except one wound infection. the costs were < ¼ of those of traditional laparoscopic sterilization and office hysteroscopic sterilization. this approach is effective for office-based laparoscopic sterilization. room air, two strings and a needle replace active gas insufflation and narcosis.","we evaluated 35 cases of a mechanical approach to abdominal wall lifting, used in office-based gasless laparoscopic sterilization under local anesthesia. lifting of the abdominal wall, using the camera trocar as an anchoring device and complemented by suprapubic lifting by means of a towel clamp, led to passive intra-abdominal air filling, giving sufficient space to identify, anesthetize, coagulate and cut the fallopian tubes. only mild sedation was necessary. all women walked to and from the operating room. all had successful tubal ligation. the overall satisfaction rate was 97%. the mechanical lifting moment was not painful. with the exception of one woman with failed tubal anesthesia, all women had a low mean pain score of 2.6 (vas 0-10). no complications occurred except one wound infection. the costs were £ 1 / 4 of those of traditional laparoscopic sterilization and office hysteroscopic sterilization. this approach is effective for office-based laparoscopic sterilization. room air, two strings and a needle replace active gas insufflation and narcosis."
sobs89-975.grobid-tei.xml,sobs89-975.nxml,abstract,ratcliff_obershelp,1,0,0,0,"we evaluated 35 cases of a mechanical approach to abdominal wall lifting, used in office-based gasless laparoscopic sterilization under local anesthesia. lifting of the abdominal wall, using the camera trocar as an anchoring device and complemented by suprapubic lifting by means of a towel clamp, led to passive intra-abdominal air filling, giving sufficient space to identify, anesthetize, coagulate and cut the fallopian tubes. only mild sedation was necessary. all women walked to and from the operating room. all had successful tubal ligation. the overall satisfaction rate was 97%. the mechanical lifting moment was not painful. with the exception of one woman with failed tubal anesthesia, all women had a low mean pain score of 2.6 (vas 0–10). no complications occurred except one wound infection. the costs were < ¼ of those of traditional laparoscopic sterilization and office hysteroscopic sterilization. this approach is effective for office-based laparoscopic sterilization. room air, two strings and a needle replace active gas insufflation and narcosis.","we evaluated 35 cases of a mechanical approach to abdominal wall lifting, used in office-based gasless laparoscopic sterilization under local anesthesia. lifting of the abdominal wall, using the camera trocar as an anchoring device and complemented by suprapubic lifting by means of a towel clamp, led to passive intra-abdominal air filling, giving sufficient space to identify, anesthetize, coagulate and cut the fallopian tubes. only mild sedation was necessary. all women walked to and from the operating room. all had successful tubal ligation. the overall satisfaction rate was 97%. the mechanical lifting moment was not painful. with the exception of one woman with failed tubal anesthesia, all women had a low mean pain score of 2.6 (vas 0-10). no complications occurred except one wound infection. the costs were £ 1 / 4 of those of traditional laparoscopic sterilization and office hysteroscopic sterilization. this approach is effective for office-based laparoscopic sterilization. room air, two strings and a needle replace active gas insufflation and narcosis."
sobs89-975.grobid-tei.xml,sobs89-975.nxml,abstract,levenshtein,1,0,0,0,"we evaluated 35 cases of a mechanical approach to abdominal wall lifting, used in office-based gasless laparoscopic sterilization under local anesthesia. lifting of the abdominal wall, using the camera trocar as an anchoring device and complemented by suprapubic lifting by means of a towel clamp, led to passive intra-abdominal air filling, giving sufficient space to identify, anesthetize, coagulate and cut the fallopian tubes. only mild sedation was necessary. all women walked to and from the operating room. all had successful tubal ligation. the overall satisfaction rate was 97%. the mechanical lifting moment was not painful. with the exception of one woman with failed tubal anesthesia, all women had a low mean pain score of 2.6 (vas 0–10). no complications occurred except one wound infection. the costs were < ¼ of those of traditional laparoscopic sterilization and office hysteroscopic sterilization. this approach is effective for office-based laparoscopic sterilization. room air, two strings and a needle replace active gas insufflation and narcosis.","we evaluated 35 cases of a mechanical approach to abdominal wall lifting, used in office-based gasless laparoscopic sterilization under local anesthesia. lifting of the abdominal wall, using the camera trocar as an anchoring device and complemented by suprapubic lifting by means of a towel clamp, led to passive intra-abdominal air filling, giving sufficient space to identify, anesthetize, coagulate and cut the fallopian tubes. only mild sedation was necessary. all women walked to and from the operating room. all had successful tubal ligation. the overall satisfaction rate was 97%. the mechanical lifting moment was not painful. with the exception of one woman with failed tubal anesthesia, all women had a low mean pain score of 2.6 (vas 0-10). no complications occurred except one wound infection. the costs were £ 1 / 4 of those of traditional laparoscopic sterilization and office hysteroscopic sterilization. this approach is effective for office-based laparoscopic sterilization. room air, two strings and a needle replace active gas insufflation and narcosis."
sobs89-975.grobid-tei.xml,sobs89-975.nxml,authors,soft,0,1,0,0,bergström,obstetriciagynecologica
sobs89-975.grobid-tei.xml,sobs89-975.nxml,authors,exact,0,1,0,0,bergström,obstetriciagynecologica
sobs89-975.grobid-tei.xml,sobs89-975.nxml,authors,ratcliff_obershelp,0,1,0,0,bergström,obstetriciagynecologica
sobs89-975.grobid-tei.xml,sobs89-975.nxml,authors,levenshtein,0,1,0,0,bergström,obstetriciagynecologica
sobs89-975.grobid-tei.xml,sobs89-975.nxml,first_author,soft,0,1,0,0,bergström,obstetricia
sobs89-975.grobid-tei.xml,sobs89-975.nxml,first_author,exact,0,1,0,0,bergström,obstetricia
sobs89-975.grobid-tei.xml,sobs89-975.nxml,first_author,ratcliff_obershelp,0,1,0,0,bergström,obstetricia
sobs89-975.grobid-tei.xml,sobs89-975.nxml,first_author,levenshtein,0,1,0,0,bergström,obstetricia
sobs89-975.grobid-tei.xml,sobs89-975.nxml,keywords,soft,1,0,0,0,femalesterilizationlaparoscopyofficegaslesslocalanesthesiasurgicaltechniquesendoscopicsurgery,femalesterilizationlaparoscopyofficegaslesslocalanesthesiasurgicaltechniquesendoscopicsurgery
sobs89-975.grobid-tei.xml,sobs89-975.nxml,keywords,exact,1,0,0,0,female sterilizationlaparoscopyofficegaslesslocal anesthesiasurgical techniquesendoscopic surgery,female sterilizationlaparoscopyofficegaslesslocal anesthesiasurgical techniquesendoscopic surgery
sobs89-975.grobid-tei.xml,sobs89-975.nxml,keywords,ratcliff_obershelp,1,0,0,0,female sterilizationlaparoscopyofficegaslesslocal anesthesiasurgical techniquesendoscopic surgery,female sterilizationlaparoscopyofficegaslesslocal anesthesiasurgical techniquesendoscopic surgery
sobs89-975.grobid-tei.xml,sobs89-975.nxml,keywords,levenshtein,1,0,0,0,female sterilizationlaparoscopyofficegaslesslocal anesthesiasurgical techniquesendoscopic surgery,female sterilizationlaparoscopyofficegaslesslocal anesthesiasurgical techniquesendoscopic surgery
sobs89-975.grobid-tei.xml,sobs89-975.nxml,title,soft,1,0,0,0,cameratrocarliftinginofficegaslesslaparoscopicsterilizationunderlocalanesthesia,cameratrocarliftinginofficegaslesslaparoscopicsterilizationunderlocalanesthesia
sobs89-975.grobid-tei.xml,sobs89-975.nxml,title,exact,1,0,0,0,camera trocar lifting in office gasless laparoscopic sterilization under local anesthesia,camera trocar lifting in office gasless laparoscopic sterilization under local anesthesia
sobs89-975.grobid-tei.xml,sobs89-975.nxml,title,ratcliff_obershelp,1,0,0,0,camera trocar lifting in office gasless laparoscopic sterilization under local anesthesia,camera trocar lifting in office gasless laparoscopic sterilization under local anesthesia
sobs89-975.grobid-tei.xml,sobs89-975.nxml,title,levenshtein,1,0,0,0,camera trocar lifting in office gasless laparoscopic sterilization under local anesthesia,camera trocar lifting in office gasless laparoscopic sterilization under local anesthesia
f-67-00344.grobid-tei.xml,f-67-00344.nxml,abstract,soft,0,1,0,0,thewholeextracellularregionsofnectin1nectin1ecandnectin2nectin2ecwereexpressedinecoliasinclusionbodiessolubilizedin8 mureaandthenrefoldedbyrapiddilutionrefoldednectin1ecandnectin2ecweresubsequentlypurifiedusingthreechromatographicstepsandcrystallizedbythehangingdropvapourdiffusionmethodthenectinfamilyofca2+independentimmunoglobulinlikecellcelladhesionmoleculescontainsfourmembersnectinswhichhavethreeiglikedomainsintheirextracellularregionformcellcelladherensjunctionscooperativelywithcadherinsthewholeextracellularregionsofnectin1nectin1ecandnectin­2nectin2ecwereexpressedinescherichiacoliasinclusionbodiessolubilizedin8 mureaandthenrefoldedbyrapiddilutionintorefoldingsolutiontherefoldedproteinsweresubsequentlypurifiedbythreechromatographicstepsandcrystallizedusingthehangingdropvapourdiffusionmethodthenectin1eccrystalsbelongedtospacegroupp213andthenectin2eccrystalsbelongedtospacegroupp6122orp6522,thenectinfamilyofca2+independentimmunoglobulinlikecellcelladhesionmoleculescontainsfourmembersnectinswhichhavethreeiglikedomainsintheirextracellularregionformcellcelladherensjunctionscooperativelywithcadherinsthewholeextracellularregionsofnectin1nectin1ecandnectin2nectin2ecwereexpressedinescherichiacoliasinclusionbodiessolubilizedin8mureaandthenrefoldedbyrapiddilutionintorefoldingsolutiontherefoldedproteinsweresubsequentlypurifiedbythreechromatographicstepsandcrystallizedusingthehangingdropvapourdiffusionmethodthenectin1eccrystalsbelongedtospacegroupp213andthenectin2eccrystalsbelongedtospacegroupp6122orp6522
f-67-00344.grobid-tei.xml,f-67-00344.nxml,abstract,exact,0,1,0,0,"the whole extracellular regions of nectin-1 (nectin-1-ec) and nectin-2 (nectin-2-ec) were expressed in e. coli as inclusion bodies, solubilized in 8 m urea and then refolded by rapid dilution. refolded nectin-1-ec and nectin-2-ec were subsequently purified using three chromatographic steps and crystallized by the hanging-drop vapour-diffusion method.the nectin family of ca2+-independent immunoglobulin-like cell–cell adhesion molecules contains four members. nectins, which have three ig-like domains in their extracellular region, form cell–cell adherens junctions cooperatively with cadherins. the whole extracellular regions of nectin-1 (nectin-1-ec) and nectin-­2 (nectin-2-ec) were expressed in escherichia coli as inclusion bodies, solubilized in 8 m urea and then refolded by rapid dilution into refolding solution. the refolded proteins were subsequently purified by three chromatographic steps and crystallized using the hanging-drop vapour-diffusion method. the nectin-1-ec crystals belonged to space group p213 and the nectin-2-ec crystals belonged to space group p6122 or p6522.","the nectin family of ca 2+-independent immunoglobulin-like cell-cell adhesion molecules contains four members. nectins, which have three ig-like domains in their extracellular region, form cell-cell adherens junctions cooperatively with cadherins. the whole extracellular regions of nectin-1 (nectin-1-ec) and nectin-2 (nectin-2-ec) were expressed in escherichia coli as inclusion bodies, solubilized in 8 m urea and then refolded by rapid dilution into refolding solution. the refolded proteins were subsequently purified by three chromato-graphic steps and crystallized using the hanging-drop vapour-diffusion method. the nectin-1-ec crystals belonged to space group p2 1 3 and the nectin-2-ec crystals belonged to space group p6 1 22 or p6 5 22."
f-67-00344.grobid-tei.xml,f-67-00344.nxml,abstract,ratcliff_obershelp,0,1,0,0,"the whole extracellular regions of nectin-1 (nectin-1-ec) and nectin-2 (nectin-2-ec) were expressed in e. coli as inclusion bodies, solubilized in 8 m urea and then refolded by rapid dilution. refolded nectin-1-ec and nectin-2-ec were subsequently purified using three chromatographic steps and crystallized by the hanging-drop vapour-diffusion method.the nectin family of ca2+-independent immunoglobulin-like cell–cell adhesion molecules contains four members. nectins, which have three ig-like domains in their extracellular region, form cell–cell adherens junctions cooperatively with cadherins. the whole extracellular regions of nectin-1 (nectin-1-ec) and nectin-­2 (nectin-2-ec) were expressed in escherichia coli as inclusion bodies, solubilized in 8 m urea and then refolded by rapid dilution into refolding solution. the refolded proteins were subsequently purified by three chromatographic steps and crystallized using the hanging-drop vapour-diffusion method. the nectin-1-ec crystals belonged to space group p213 and the nectin-2-ec crystals belonged to space group p6122 or p6522.","the nectin family of ca 2+-independent immunoglobulin-like cell-cell adhesion molecules contains four members. nectins, which have three ig-like domains in their extracellular region, form cell-cell adherens junctions cooperatively with cadherins. the whole extracellular regions of nectin-1 (nectin-1-ec) and nectin-2 (nectin-2-ec) were expressed in escherichia coli as inclusion bodies, solubilized in 8 m urea and then refolded by rapid dilution into refolding solution. the refolded proteins were subsequently purified by three chromato-graphic steps and crystallized using the hanging-drop vapour-diffusion method. the nectin-1-ec crystals belonged to space group p2 1 3 and the nectin-2-ec crystals belonged to space group p6 1 22 or p6 5 22."
f-67-00344.grobid-tei.xml,f-67-00344.nxml,abstract,levenshtein,0,1,0,0,"the whole extracellular regions of nectin-1 (nectin-1-ec) and nectin-2 (nectin-2-ec) were expressed in e. coli as inclusion bodies, solubilized in 8 m urea and then refolded by rapid dilution. refolded nectin-1-ec and nectin-2-ec were subsequently purified using three chromatographic steps and crystallized by the hanging-drop vapour-diffusion method.the nectin family of ca2+-independent immunoglobulin-like cell–cell adhesion molecules contains four members. nectins, which have three ig-like domains in their extracellular region, form cell–cell adherens junctions cooperatively with cadherins. the whole extracellular regions of nectin-1 (nectin-1-ec) and nectin-­2 (nectin-2-ec) were expressed in escherichia coli as inclusion bodies, solubilized in 8 m urea and then refolded by rapid dilution into refolding solution. the refolded proteins were subsequently purified by three chromatographic steps and crystallized using the hanging-drop vapour-diffusion method. the nectin-1-ec crystals belonged to space group p213 and the nectin-2-ec crystals belonged to space group p6122 or p6522.","the nectin family of ca 2+-independent immunoglobulin-like cell-cell adhesion molecules contains four members. nectins, which have three ig-like domains in their extracellular region, form cell-cell adherens junctions cooperatively with cadherins. the whole extracellular regions of nectin-1 (nectin-1-ec) and nectin-2 (nectin-2-ec) were expressed in escherichia coli as inclusion bodies, solubilized in 8 m urea and then refolded by rapid dilution into refolding solution. the refolded proteins were subsequently purified by three chromato-graphic steps and crystallized using the hanging-drop vapour-diffusion method. the nectin-1-ec crystals belonged to space group p2 1 3 and the nectin-2-ec crystals belonged to space group p6 1 22 or p6 5 22."
f-67-00344.grobid-tei.xml,f-67-00344.nxml,authors,soft,1,0,0,0,naritanakagawayamamotosakisakatakaisuzuki,naritanakagawayamamotosakisakatakaisuzuki
f-67-00344.grobid-tei.xml,f-67-00344.nxml,authors,exact,1,0,0,0,naritanakagawayamamotosakisakatakaisuzuki,naritanakagawayamamotosakisakatakaisuzuki
f-67-00344.grobid-tei.xml,f-67-00344.nxml,authors,ratcliff_obershelp,1,0,0,0,naritanakagawayamamotosakisakatakaisuzuki,naritanakagawayamamotosakisakatakaisuzuki
f-67-00344.grobid-tei.xml,f-67-00344.nxml,authors,levenshtein,1,0,0,0,naritanakagawayamamotosakisakatakaisuzuki,naritanakagawayamamotosakisakatakaisuzuki
f-67-00344.grobid-tei.xml,f-67-00344.nxml,first_author,soft,1,0,0,0,narita,narita
f-67-00344.grobid-tei.xml,f-67-00344.nxml,first_author,exact,1,0,0,0,narita,narita
f-67-00344.grobid-tei.xml,f-67-00344.nxml,first_author,ratcliff_obershelp,1,0,0,0,narita,narita
f-67-00344.grobid-tei.xml,f-67-00344.nxml,first_author,levenshtein,1,0,0,0,narita,narita
f-67-00344.grobid-tei.xml,f-67-00344.nxml,keywords,soft,0,0,1,0,celladhesionmoleculesimmunoglobulinlikedomainsadherensjunctions,
f-67-00344.grobid-tei.xml,f-67-00344.nxml,keywords,exact,0,0,1,0,cell-adhesion moleculesimmunoglobulin-like domainsadherens junctions,
f-67-00344.grobid-tei.xml,f-67-00344.nxml,keywords,ratcliff_obershelp,0,0,1,0,cell-adhesion moleculesimmunoglobulin-like domainsadherens junctions,
f-67-00344.grobid-tei.xml,f-67-00344.nxml,keywords,levenshtein,0,0,1,0,cell-adhesion moleculesimmunoglobulin-like domainsadherens junctions,
f-67-00344.grobid-tei.xml,f-67-00344.nxml,title,soft,0,1,0,0,refoldingcrystallizationandpreliminaryxraycrystallographicstudyofthewholeextracellularregionsofnectins,structuralbiologyandcrystallizationcommunicationsrefoldingcrystallizationandpreliminaryxraycrystallographicstudyofthewholeextracellularregionsofnectins
f-67-00344.grobid-tei.xml,f-67-00344.nxml,title,exact,0,1,0,0,"refolding, crystallization and preliminary x-ray crystallographic study of the whole extracellular regions of nectins","structural biology and crystallization communications refolding, crystallization and preliminary x-ray crystallographic study of the whole extracellular regions of nectins"
f-67-00344.grobid-tei.xml,f-67-00344.nxml,title,ratcliff_obershelp,0,1,0,0,"refolding, crystallization and preliminary x-ray crystallographic study of the whole extracellular regions of nectins","structural biology and crystallization communications refolding, crystallization and preliminary x-ray crystallographic study of the whole extracellular regions of nectins"
f-67-00344.grobid-tei.xml,f-67-00344.nxml,title,levenshtein,0,1,0,0,"refolding, crystallization and preliminary x-ray crystallographic study of the whole extracellular regions of nectins","structural biology and crystallization communications refolding, crystallization and preliminary x-ray crystallographic study of the whole extracellular regions of nectins"
ORT-1745-3674-81-405.grobid-tei.xml,ORT-1745-3674-81-405.nxml,abstract,soft,0,0,0,1,,
ORT-1745-3674-81-405.grobid-tei.xml,ORT-1745-3674-81-405.nxml,abstract,exact,0,0,0,1,,
ORT-1745-3674-81-405.grobid-tei.xml,ORT-1745-3674-81-405.nxml,abstract,ratcliff_obershelp,0,0,0,1,,
ORT-1745-3674-81-405.grobid-tei.xml,ORT-1745-3674-81-405.nxml,abstract,levenshtein,0,0,0,1,,
ORT-1745-3674-81-405.grobid-tei.xml,ORT-1745-3674-81-405.nxml,authors,soft,1,0,0,0,schmitzdewaalmalefijtvanheereveld,schmitzdewaalmalefijtvanheereveld
ORT-1745-3674-81-405.grobid-tei.xml,ORT-1745-3674-81-405.nxml,authors,exact,1,0,0,0,schmitzde waal malefijtvan heereveld,schmitzde waal malefijtvan heereveld
ORT-1745-3674-81-405.grobid-tei.xml,ORT-1745-3674-81-405.nxml,authors,ratcliff_obershelp,1,0,0,0,schmitzde waal malefijtvan heereveld,schmitzde waal malefijtvan heereveld
ORT-1745-3674-81-405.grobid-tei.xml,ORT-1745-3674-81-405.nxml,authors,levenshtein,1,0,0,0,schmitzde waal malefijtvan heereveld,schmitzde waal malefijtvan heereveld
ORT-1745-3674-81-405.grobid-tei.xml,ORT-1745-3674-81-405.nxml,first_author,soft,1,0,0,0,schmitz,schmitz
ORT-1745-3674-81-405.grobid-tei.xml,ORT-1745-3674-81-405.nxml,first_author,exact,1,0,0,0,schmitz,schmitz
ORT-1745-3674-81-405.grobid-tei.xml,ORT-1745-3674-81-405.nxml,first_author,ratcliff_obershelp,1,0,0,0,schmitz,schmitz
ORT-1745-3674-81-405.grobid-tei.xml,ORT-1745-3674-81-405.nxml,first_author,levenshtein,1,0,0,0,schmitz,schmitz
ORT-1745-3674-81-405.grobid-tei.xml,ORT-1745-3674-81-405.nxml,keywords,soft,0,0,0,1,,
ORT-1745-3674-81-405.grobid-tei.xml,ORT-1745-3674-81-405.nxml,keywords,exact,0,0,0,1,,
ORT-1745-3674-81-405.grobid-tei.xml,ORT-1745-3674-81-405.nxml,keywords,ratcliff_obershelp,0,0,0,1,,
ORT-1745-3674-81-405.grobid-tei.xml,ORT-1745-3674-81-405.nxml,keywords,levenshtein,0,0,0,1,,
ORT-1745-3674-81-405.grobid-tei.xml,ORT-1745-3674-81-405.nxml,title,soft,0,1,0,0,resectionarthroplastyforluxationofthemanubriosternaljointinrheumatoidarthritis—acasereport,resectionarthroplastyforluxationofthemanubriosternaljointinrheumatoidarthritisacasereport
ORT-1745-3674-81-405.grobid-tei.xml,ORT-1745-3674-81-405.nxml,title,exact,0,1,0,0,resection arthroplasty for luxation of the manubrio-sternal joint in rheumatoid arthritis—a case report,resection arthroplasty for luxation of the manubrio-sternal joint in rheumatoid arthritis-a case report
ORT-1745-3674-81-405.grobid-tei.xml,ORT-1745-3674-81-405.nxml,title,ratcliff_obershelp,1,0,0,0,resection arthroplasty for luxation of the manubrio-sternal joint in rheumatoid arthritis—a case report,resection arthroplasty for luxation of the manubrio-sternal joint in rheumatoid arthritis-a case report
ORT-1745-3674-81-405.grobid-tei.xml,ORT-1745-3674-81-405.nxml,title,levenshtein,1,0,0,0,resection arthroplasty for luxation of the manubrio-sternal joint in rheumatoid arthritis—a case report,resection arthroplasty for luxation of the manubrio-sternal joint in rheumatoid arthritis-a case report
soto131-469.grobid-tei.xml,soto131-469.nxml,abstract,soft,1,0,0,0,conclusionthesaccularductandendolymphaticsinusruninthebonygroovebeforereachingtheorificeofthevestibularaqueductwefirstclinicallyvisualizedthissulciformgrooveusingthreedimensional3dconebeamctimagesthisstrategycanbeusefultoassesstheconditionofthesaccularductandendolymphaticsinusconcerningthelongitudinalflowsystemofendolymphobjectivetoassessthesaccularductandendolymphaticsinusintheendolymphaticsysteminordertoadvanceclinicalstudiesoninnereardysfunctionmethodsthesulciformgrooveofthesaccularductandendolymphaticsinusofhumansubjectswasanalyzedbyconebeamctandcomparedwiththatofacadaverresultswecouldobtainreconstructed3dctimagesofthesulciformgrooveofthesaccularductandendolymphaticsinususingseveralctwindowlevels,conclusionthesaccularductandendolymphaticsinusruninthebonygroovebeforereachingtheorificeofthevestibularaqueductwefirstclinicallyvisualizedthissulciformgrooveusingthreedimensional3dconebeamctimagesthisstrategycanbeusefultoassesstheconditionofthesaccularductandendolymphaticsinusconcerningthelongitudinalflowsystemofendolymphobjectivetoassessthesaccularductandendolymphaticsinusintheendolymphaticsysteminordertoadvanceclinicalstudiesoninnereardysfunctionmethodsthesulciformgrooveofthesaccularductandendolymphaticsinusofhumansubjectswasanalyzedbyconebeamctandcomparedwiththatofacadaverresultswecouldobtainreconstructed3dctimagesofthesulciformgrooveofthesaccularductandendolymphaticsinususingseveralctwindowlevels
soto131-469.grobid-tei.xml,soto131-469.nxml,abstract,exact,1,0,0,0,"conclusion: the saccular duct and endolymphatic sinus run in the bony groove, before reaching the orifice of the vestibular aqueduct. we first clinically visualized this sulciform groove using three-dimensional (3d) cone beam ct images. this strategy can be useful to assess the condition of the saccular duct and endolymphatic sinus concerning the longitudinal flow system of endolymph. objective: to assess the saccular duct and endolymphatic sinus in the endolymphatic system in order to advance clinical studies on inner ear dysfunction. methods: the sulciform groove of the saccular duct and endolymphatic sinus of human subjects was analyzed by cone beam ct and compared with that of a cadaver. results: we could obtain reconstructed 3d ct images of the sulciform groove of the saccular duct and endolymphatic sinus using several ct window levels.","conclusion: the saccular duct and endolymphatic sinus run in the bony groove, before reaching the orifice of the vestibular aqueduct. we first clinically visualized this sulciform groove using three-dimensional (3d) cone beam ct images. this strategy can be useful to assess the condition of the saccular duct and endolymphatic sinus concerning the longitudinal flow system of endolymph. objective: to assess the saccular duct and endolymphatic sinus in the endolymphatic system in order to advance clinical studies on inner ear dysfunction. methods: the sulciform groove of the saccular duct and endolymphatic sinus of human subjects was analyzed by cone beam ct and compared with that of a cadaver. results: we could obtain reconstructed 3d ct images of the sulciform groove of the saccular duct and endolymphatic sinus using several ct window levels."
soto131-469.grobid-tei.xml,soto131-469.nxml,abstract,ratcliff_obershelp,1,0,0,0,"conclusion: the saccular duct and endolymphatic sinus run in the bony groove, before reaching the orifice of the vestibular aqueduct. we first clinically visualized this sulciform groove using three-dimensional (3d) cone beam ct images. this strategy can be useful to assess the condition of the saccular duct and endolymphatic sinus concerning the longitudinal flow system of endolymph. objective: to assess the saccular duct and endolymphatic sinus in the endolymphatic system in order to advance clinical studies on inner ear dysfunction. methods: the sulciform groove of the saccular duct and endolymphatic sinus of human subjects was analyzed by cone beam ct and compared with that of a cadaver. results: we could obtain reconstructed 3d ct images of the sulciform groove of the saccular duct and endolymphatic sinus using several ct window levels.","conclusion: the saccular duct and endolymphatic sinus run in the bony groove, before reaching the orifice of the vestibular aqueduct. we first clinically visualized this sulciform groove using three-dimensional (3d) cone beam ct images. this strategy can be useful to assess the condition of the saccular duct and endolymphatic sinus concerning the longitudinal flow system of endolymph. objective: to assess the saccular duct and endolymphatic sinus in the endolymphatic system in order to advance clinical studies on inner ear dysfunction. methods: the sulciform groove of the saccular duct and endolymphatic sinus of human subjects was analyzed by cone beam ct and compared with that of a cadaver. results: we could obtain reconstructed 3d ct images of the sulciform groove of the saccular duct and endolymphatic sinus using several ct window levels."
soto131-469.grobid-tei.xml,soto131-469.nxml,abstract,levenshtein,1,0,0,0,"conclusion: the saccular duct and endolymphatic sinus run in the bony groove, before reaching the orifice of the vestibular aqueduct. we first clinically visualized this sulciform groove using three-dimensional (3d) cone beam ct images. this strategy can be useful to assess the condition of the saccular duct and endolymphatic sinus concerning the longitudinal flow system of endolymph. objective: to assess the saccular duct and endolymphatic sinus in the endolymphatic system in order to advance clinical studies on inner ear dysfunction. methods: the sulciform groove of the saccular duct and endolymphatic sinus of human subjects was analyzed by cone beam ct and compared with that of a cadaver. results: we could obtain reconstructed 3d ct images of the sulciform groove of the saccular duct and endolymphatic sinus using several ct window levels.","conclusion: the saccular duct and endolymphatic sinus run in the bony groove, before reaching the orifice of the vestibular aqueduct. we first clinically visualized this sulciform groove using three-dimensional (3d) cone beam ct images. this strategy can be useful to assess the condition of the saccular duct and endolymphatic sinus concerning the longitudinal flow system of endolymph. objective: to assess the saccular duct and endolymphatic sinus in the endolymphatic system in order to advance clinical studies on inner ear dysfunction. methods: the sulciform groove of the saccular duct and endolymphatic sinus of human subjects was analyzed by cone beam ct and compared with that of a cadaver. results: we could obtain reconstructed 3d ct images of the sulciform groove of the saccular duct and endolymphatic sinus using several ct window levels."
soto131-469.grobid-tei.xml,soto131-469.nxml,authors,soft,1,0,0,0,yamanetakayamasunamisakamotoimotoanniko,yamanetakayamasunamisakamotoimotoanniko
soto131-469.grobid-tei.xml,soto131-469.nxml,authors,exact,1,0,0,0,yamanetakayamasunamisakamotoimotoanniko,yamanetakayamasunamisakamotoimotoanniko
soto131-469.grobid-tei.xml,soto131-469.nxml,authors,ratcliff_obershelp,1,0,0,0,yamanetakayamasunamisakamotoimotoanniko,yamanetakayamasunamisakamotoimotoanniko
soto131-469.grobid-tei.xml,soto131-469.nxml,authors,levenshtein,1,0,0,0,yamanetakayamasunamisakamotoimotoanniko,yamanetakayamasunamisakamotoimotoanniko
soto131-469.grobid-tei.xml,soto131-469.nxml,first_author,soft,1,0,0,0,yamane,yamane
soto131-469.grobid-tei.xml,soto131-469.nxml,first_author,exact,1,0,0,0,yamane,yamane
soto131-469.grobid-tei.xml,soto131-469.nxml,first_author,ratcliff_obershelp,1,0,0,0,yamane,yamane
soto131-469.grobid-tei.xml,soto131-469.nxml,first_author,levenshtein,1,0,0,0,yamane,yamane
soto131-469.grobid-tei.xml,soto131-469.nxml,keywords,soft,1,0,0,0,cochleasacculebonygroovelongitudinalflowctimageendolymphatichydropsendolymphaticductrendering,cochleasacculebonygroovelongitudinalflowctimageendolymphatichydropsendolymphaticductrendering
soto131-469.grobid-tei.xml,soto131-469.nxml,keywords,exact,1,0,0,0,cochleasacculebony groovelongitudinal flowct imageendolymphatic hydropsendolymphatic ductrendering,cochleasacculebony groovelongitudinal flowct imageendolymphatic hydropsendolymphatic ductrendering
soto131-469.grobid-tei.xml,soto131-469.nxml,keywords,ratcliff_obershelp,1,0,0,0,cochleasacculebony groovelongitudinal flowct imageendolymphatic hydropsendolymphatic ductrendering,cochleasacculebony groovelongitudinal flowct imageendolymphatic hydropsendolymphatic ductrendering
soto131-469.grobid-tei.xml,soto131-469.nxml,keywords,levenshtein,1,0,0,0,cochleasacculebony groovelongitudinal flowct imageendolymphatic hydropsendolymphatic ductrendering,cochleasacculebony groovelongitudinal flowct imageendolymphatic hydropsendolymphatic ductrendering
soto131-469.grobid-tei.xml,soto131-469.nxml,title,soft,1,0,0,0,visualizationandassessmentofsaccularductandendolymphaticsinus,visualizationandassessmentofsaccularductandendolymphaticsinus
soto131-469.grobid-tei.xml,soto131-469.nxml,title,exact,1,0,0,0,visualization and assessment of saccular duct and endolymphatic sinus,visualization and assessment of saccular duct and endolymphatic sinus
soto131-469.grobid-tei.xml,soto131-469.nxml,title,ratcliff_obershelp,1,0,0,0,visualization and assessment of saccular duct and endolymphatic sinus,visualization and assessment of saccular duct and endolymphatic sinus
soto131-469.grobid-tei.xml,soto131-469.nxml,title,levenshtein,1,0,0,0,visualization and assessment of saccular duct and endolymphatic sinus,visualization and assessment of saccular duct and endolymphatic sinus
sonc50-621.grobid-tei.xml,sonc50-621.nxml,abstract,soft,0,1,0,0,backgroundcutaneousmetastasesmaycauseconsiderablediscomfortasaconsequenceofulcerationoozingbleedingandpainelectrochemotherapyhasproventobehighlyeffectiveinthetreatmentofcutaneousmetastaseselectrochemotherapyutilisespulsesofelectricitytoincreasethepermeabilityofthecellmembraneandtherebyaugmenttheeffectofchemotherapyforthedrugbleomycintheeffectisenhancedseveralhundredfoldenablingonceonlytreatmenttheprimaryendpointofthisstudyistoevaluatetheefficacyofelectrochemotherapyasapalliativetreatmentmethodsthisphaseiistudyisacollaborationbetweentwocentresoneindenmarkandtheotherintheukpatientswithcutaneousmetastasesofanyhistologywereincludedbleomycinwasadministeredintratumourallyorintravenouslyfollowedbyapplicationofelectricpulsestothetumoursiteresultsfiftytwopatientswereincludedcompleteandpartialresponseratewas68%and18%respectivelyforcutaneousmetastases<3cmand8%and23%respectivelyforcutaneousmetastases>3cmtreatmentwaswelltoleratedbypatientsincludingtheelderlyandnoseriousadverseeventswereobservedconclusionsectisanefficientandsafetreatmentandcliniciansshouldnothesitatetouseitevenintheelderly,backgroundcutaneousmetastasesmaycauseconsiderablediscomfortasaconsequenceofulcerationoozingbleedingandpainelectrochemotherapyhasproventobehighlyeffectiveinthetreatmentofcutaneousmetastaseselectrochemotherapyutilisespulsesofelectricitytoincreasethepermeabilityofthecellmembraneandtherebyaugmenttheeffectofchemotherapyforthedrugbleomycintheeffectisenhancedseveralhundredfoldenablingonceonlytreatmenttheprimaryendpointofthisstudyistoevaluatetheefficacyofelectrochemotherapyasapalliativetreatmentmethodsthisphaseiistudyisacollaborationbetweentwocentresoneindenmarkandtheotherintheukpatientswithcutaneousmetastasesofanyhistologywereincludedbleomycinwasadministeredintratumourallyorintravenouslyfollowedbyapplicationofelectricpulsestothetumoursiteresultsfiftytwopatientswereincludedcompleteandpartialresponseratewas68%and18%respectivelyforcutaneousmetastases3cmand8%and23%respectivelyforcutaneousmetastases3cmtreatmentwaswelltoleratedbypatientsincludingtheelderlyandnoseriousadverseeventswereobservedconclusionsectisanefficientandsafetreatmentandcliniciansshouldnothesitatetouseitevenintheelderlyacutaneousmetastasiscanbedefinedasaneoplasticlesionarisingfromanotherneoplasmwithwhichthereisnolongercontinuity1cutaneousmetastasesaccountfor07%to9%ofallmetastases2breastcanceraccountsfor51%ofthetotalcasesofcutaneousmetastaseswhilemalignantmelanomaaccountsfor18%3
sonc50-621.grobid-tei.xml,sonc50-621.nxml,abstract,exact,0,1,0,0,"background. cutaneous metastases may cause considerable discomfort as a consequence of ulceration, oozing, bleeding and pain. electrochemotherapy has proven to be highly effective in the treatment of cutaneous metastases. electrochemotherapy utilises pulses of electricity to increase the permeability of the cell membrane and thereby augment the effect of chemotherapy. for the drug bleomycin, the effect is enhanced several hundred-fold, enabling once-only treatment. the primary endpoint of this study is to evaluate the efficacy of electrochemotherapy as a palliative treatment. methods. this phase ii study is a collaboration between two centres, one in denmark and the other in the uk. patients with cutaneous metastases of any histology were included. bleomycin was administered intratumourally or intravenously followed by application of electric pulses to the tumour site. results. fifty-two patients were included. complete and partial response rate was 68% and 18%, respectively, for cutaneous metastases <3 cm and 8% and 23%, respectively, for cutaneous metastases >3 cm. treatment was well-tolerated by patients, including the elderly, and no serious adverse events were observed. conclusions. ect is an efficient and safe treatment and clinicians should not hesitate to use it even in the elderly.","background. cutaneous metastases may cause considerable discomfort as a consequence of ulceration, oozing, bleeding and pain. electrochemotherapy has proven to be highly effective in the treatment of cutaneous metastases. electrochemo-therapy utilises pulses of electricity to increase the permeability of the cell membrane and thereby augment the effect of chemotherapy. for the drug bleomycin, the effect is enhanced several hundred-fold, enabling once-only treatment. the primary endpoint of this study is to evaluate the effi cacy of electrochemotherapy as a palliative treatment. methods. this phase ii study is a collaboration between two centres, one in denmark and the other in the uk. patients with cutaneous metastases of any histology were included. bleomycin was administered intratumourally or intravenously followed by application of electric pulses to the tumour site. results. fifty-two patients were included. complete and partial response rate was 68% and 18%, respectively, for cutaneous metastases 3 cm and 8% and 23%, respectively, for cutaneous metastases 3 cm. treatment was well-tolerated by patients, including the elderly, and no serious adverse events were observed. conclusions. ect is an effi cient and safe treatment and clinicians should not hesitate to use it even in the elderly. a cutaneous metastasis can be defi ned as "" a neoplas-tic lesion arising from another neoplasm with which there is no longer continuity "" [1]. cutaneous metas-tases account for 0.7% to 9% of all metastases [2]. breast cancer accounts for 51% of the total cases of cutaneous metastases, while malignant melanoma accounts for 18% [3]."
sonc50-621.grobid-tei.xml,sonc50-621.nxml,abstract,ratcliff_obershelp,0,1,0,0,"background. cutaneous metastases may cause considerable discomfort as a consequence of ulceration, oozing, bleeding and pain. electrochemotherapy has proven to be highly effective in the treatment of cutaneous metastases. electrochemotherapy utilises pulses of electricity to increase the permeability of the cell membrane and thereby augment the effect of chemotherapy. for the drug bleomycin, the effect is enhanced several hundred-fold, enabling once-only treatment. the primary endpoint of this study is to evaluate the efficacy of electrochemotherapy as a palliative treatment. methods. this phase ii study is a collaboration between two centres, one in denmark and the other in the uk. patients with cutaneous metastases of any histology were included. bleomycin was administered intratumourally or intravenously followed by application of electric pulses to the tumour site. results. fifty-two patients were included. complete and partial response rate was 68% and 18%, respectively, for cutaneous metastases <3 cm and 8% and 23%, respectively, for cutaneous metastases >3 cm. treatment was well-tolerated by patients, including the elderly, and no serious adverse events were observed. conclusions. ect is an efficient and safe treatment and clinicians should not hesitate to use it even in the elderly.","background. cutaneous metastases may cause considerable discomfort as a consequence of ulceration, oozing, bleeding and pain. electrochemotherapy has proven to be highly effective in the treatment of cutaneous metastases. electrochemo-therapy utilises pulses of electricity to increase the permeability of the cell membrane and thereby augment the effect of chemotherapy. for the drug bleomycin, the effect is enhanced several hundred-fold, enabling once-only treatment. the primary endpoint of this study is to evaluate the effi cacy of electrochemotherapy as a palliative treatment. methods. this phase ii study is a collaboration between two centres, one in denmark and the other in the uk. patients with cutaneous metastases of any histology were included. bleomycin was administered intratumourally or intravenously followed by application of electric pulses to the tumour site. results. fifty-two patients were included. complete and partial response rate was 68% and 18%, respectively, for cutaneous metastases 3 cm and 8% and 23%, respectively, for cutaneous metastases 3 cm. treatment was well-tolerated by patients, including the elderly, and no serious adverse events were observed. conclusions. ect is an effi cient and safe treatment and clinicians should not hesitate to use it even in the elderly. a cutaneous metastasis can be defi ned as "" a neoplas-tic lesion arising from another neoplasm with which there is no longer continuity "" [1]. cutaneous metas-tases account for 0.7% to 9% of all metastases [2]. breast cancer accounts for 51% of the total cases of cutaneous metastases, while malignant melanoma accounts for 18% [3]."
sonc50-621.grobid-tei.xml,sonc50-621.nxml,abstract,levenshtein,0,1,0,0,"background. cutaneous metastases may cause considerable discomfort as a consequence of ulceration, oozing, bleeding and pain. electrochemotherapy has proven to be highly effective in the treatment of cutaneous metastases. electrochemotherapy utilises pulses of electricity to increase the permeability of the cell membrane and thereby augment the effect of chemotherapy. for the drug bleomycin, the effect is enhanced several hundred-fold, enabling once-only treatment. the primary endpoint of this study is to evaluate the efficacy of electrochemotherapy as a palliative treatment. methods. this phase ii study is a collaboration between two centres, one in denmark and the other in the uk. patients with cutaneous metastases of any histology were included. bleomycin was administered intratumourally or intravenously followed by application of electric pulses to the tumour site. results. fifty-two patients were included. complete and partial response rate was 68% and 18%, respectively, for cutaneous metastases <3 cm and 8% and 23%, respectively, for cutaneous metastases >3 cm. treatment was well-tolerated by patients, including the elderly, and no serious adverse events were observed. conclusions. ect is an efficient and safe treatment and clinicians should not hesitate to use it even in the elderly.","background. cutaneous metastases may cause considerable discomfort as a consequence of ulceration, oozing, bleeding and pain. electrochemotherapy has proven to be highly effective in the treatment of cutaneous metastases. electrochemo-therapy utilises pulses of electricity to increase the permeability of the cell membrane and thereby augment the effect of chemotherapy. for the drug bleomycin, the effect is enhanced several hundred-fold, enabling once-only treatment. the primary endpoint of this study is to evaluate the effi cacy of electrochemotherapy as a palliative treatment. methods. this phase ii study is a collaboration between two centres, one in denmark and the other in the uk. patients with cutaneous metastases of any histology were included. bleomycin was administered intratumourally or intravenously followed by application of electric pulses to the tumour site. results. fifty-two patients were included. complete and partial response rate was 68% and 18%, respectively, for cutaneous metastases 3 cm and 8% and 23%, respectively, for cutaneous metastases 3 cm. treatment was well-tolerated by patients, including the elderly, and no serious adverse events were observed. conclusions. ect is an effi cient and safe treatment and clinicians should not hesitate to use it even in the elderly. a cutaneous metastasis can be defi ned as "" a neoplas-tic lesion arising from another neoplasm with which there is no longer continuity "" [1]. cutaneous metas-tases account for 0.7% to 9% of all metastases [2]. breast cancer accounts for 51% of the total cases of cutaneous metastases, while malignant melanoma accounts for 18% [3]."
sonc50-621.grobid-tei.xml,sonc50-621.nxml,authors,soft,0,1,0,0,matthiessenchalmerssainsburyveeramanikessellhumphreysbondmuirgehl,gehlwichmannmatthiessenchalmerschristophersainsburyveeramanikessellhumphreysbondmuirgehl
sonc50-621.grobid-tei.xml,sonc50-621.nxml,authors,exact,0,1,0,0,matthiessenchalmerssainsburyveeramanikessellhumphreysbondmuirgehl,gehlwichmann matthiessenchalmerschristophersainsburyveeramanikessellhumphreysbondmuirgehl
sonc50-621.grobid-tei.xml,sonc50-621.nxml,authors,ratcliff_obershelp,0,1,0,0,matthiessenchalmerssainsburyveeramanikessellhumphreysbondmuirgehl,gehlwichmann matthiessenchalmerschristophersainsburyveeramanikessellhumphreysbondmuirgehl
sonc50-621.grobid-tei.xml,sonc50-621.nxml,authors,levenshtein,0,1,0,0,matthiessenchalmerssainsburyveeramanikessellhumphreysbondmuirgehl,gehlwichmann matthiessenchalmerschristophersainsburyveeramanikessellhumphreysbondmuirgehl
sonc50-621.grobid-tei.xml,sonc50-621.nxml,first_author,soft,0,1,0,0,matthiessen,gehl
sonc50-621.grobid-tei.xml,sonc50-621.nxml,first_author,exact,0,1,0,0,matthiessen,gehl
sonc50-621.grobid-tei.xml,sonc50-621.nxml,first_author,ratcliff_obershelp,0,1,0,0,matthiessen,gehl
sonc50-621.grobid-tei.xml,sonc50-621.nxml,first_author,levenshtein,0,1,0,0,matthiessen,gehl
sonc50-621.grobid-tei.xml,sonc50-621.nxml,keywords,soft,0,0,0,1,,
sonc50-621.grobid-tei.xml,sonc50-621.nxml,keywords,exact,0,0,0,1,,
sonc50-621.grobid-tei.xml,sonc50-621.nxml,keywords,ratcliff_obershelp,0,0,0,1,,
sonc50-621.grobid-tei.xml,sonc50-621.nxml,keywords,levenshtein,0,0,0,1,,
sonc50-621.grobid-tei.xml,sonc50-621.nxml,title,soft,1,0,0,0,managementofcutaneousmetastasesusingelectrochemotherapy,managementofcutaneousmetastasesusingelectrochemotherapy
sonc50-621.grobid-tei.xml,sonc50-621.nxml,title,exact,1,0,0,0,management of cutaneous metastases using electrochemotherapy,management of cutaneous metastases using electrochemotherapy
sonc50-621.grobid-tei.xml,sonc50-621.nxml,title,ratcliff_obershelp,1,0,0,0,management of cutaneous metastases using electrochemotherapy,management of cutaneous metastases using electrochemotherapy
sonc50-621.grobid-tei.xml,sonc50-621.nxml,title,levenshtein,1,0,0,0,management of cutaneous metastases using electrochemotherapy,management of cutaneous metastases using electrochemotherapy
d-67-00463.grobid-tei.xml,d-67-00463.nxml,abstract,soft,0,1,0,0,pisamplingderivedfromtheincompletefactorialapproachisanefforttomaximizethediversityofmacromolecularcrystallizationconditionsandtofacilitatethepreparationof96conditioninitialscreensthepisamplingmethodisderivedfromtheincompletefactorialapproachtomacromolecularcrystallizationscreendesigntheresultingpiscreenshaveamodulardistributionofagivensetofupto36stocksolutionsmaximallydiverseconditionscanbeproducedbytakingintoaccountthepropertiesofthechemicalsusedintheformulationandtheconcentrationsofthecorrespondingsolutionsthepisamplingmethodhasbeenimplementedinawebbasedapplicationthatgeneratesscreenformulationsandrecipesitisparticularlyadaptedtoscreensconsistingof96differentconditionstheflexibilityandefficiencyofpisamplingisdemonstratedbythecrystallizationofsolubleproteinsandofanintegralmembraneproteinsample,thepisamplingmethodisderivedfromtheincompletefactorialapproachtomacromolecularcrystallizationscreendesigntheresultingpiscreenshaveamodulardistributionofagivensetofupto36stocksolutionsmaximallydiverseconditionscanbeproducedbytakingintoaccountthepropertiesofthechemicalsusedintheformulationandtheconcentrationsofthecorrespondingsolutionsthepisamplingmethodhasbeenimplementedinawebbasedapplicationthatgeneratesscreenformulationsandrecipesitisparticularlyadaptedtoscreensconsistingof96differentconditionstheflexibilityandefficiencyofpisamplingisdemonstratedbythecrystallizationofsolubleproteinsandofanintegralmembraneproteinsample
d-67-00463.grobid-tei.xml,d-67-00463.nxml,abstract,exact,0,1,0,0,"pi sampling, derived from the incomplete factorial approach, is an effort to maximize the diversity of macromolecular crystallization conditions and to facilitate the preparation of 96-condition initial screens.the pi sampling method is derived from the incomplete factorial approach to macromolecular crystallization screen design. the resulting ‘pi screens’ have a modular distribution of a given set of up to 36 stock solutions. maximally diverse conditions can be produced by taking into account the properties of the chemicals used in the formulation and the concentrations of the corresponding solutions. the pi sampling method has been implemented in a web-based application that generates screen formulations and recipes. it is particularly adapted to screens consisting of 96 different conditions. the flexibility and efficiency of pi sampling is demonstrated by the crystallization of soluble proteins and of an integral membrane-protein sample.",the pi sampling method is derived from the incomplete factorial approach to macromolecular crystallization screen design. the resulting 'pi screens' have a modular distribution of a given set of up to 36 stock solutions. maximally diverse conditions can be produced by taking into account the properties of the chemicals used in the formulation and the concentrations of the corresponding solutions. the pi sampling method has been implemented in a web-based application that generates screen formulations and recipes. it is particularly adapted to screens consisting of 96 different conditions. the flexibility and efficiency of pi sampling is demonstrated by the crystallization of soluble proteins and of an integral membrane-protein sample.
d-67-00463.grobid-tei.xml,d-67-00463.nxml,abstract,ratcliff_obershelp,0,1,0,0,"pi sampling, derived from the incomplete factorial approach, is an effort to maximize the diversity of macromolecular crystallization conditions and to facilitate the preparation of 96-condition initial screens.the pi sampling method is derived from the incomplete factorial approach to macromolecular crystallization screen design. the resulting ‘pi screens’ have a modular distribution of a given set of up to 36 stock solutions. maximally diverse conditions can be produced by taking into account the properties of the chemicals used in the formulation and the concentrations of the corresponding solutions. the pi sampling method has been implemented in a web-based application that generates screen formulations and recipes. it is particularly adapted to screens consisting of 96 different conditions. the flexibility and efficiency of pi sampling is demonstrated by the crystallization of soluble proteins and of an integral membrane-protein sample.",the pi sampling method is derived from the incomplete factorial approach to macromolecular crystallization screen design. the resulting 'pi screens' have a modular distribution of a given set of up to 36 stock solutions. maximally diverse conditions can be produced by taking into account the properties of the chemicals used in the formulation and the concentrations of the corresponding solutions. the pi sampling method has been implemented in a web-based application that generates screen formulations and recipes. it is particularly adapted to screens consisting of 96 different conditions. the flexibility and efficiency of pi sampling is demonstrated by the crystallization of soluble proteins and of an integral membrane-protein sample.
d-67-00463.grobid-tei.xml,d-67-00463.nxml,abstract,levenshtein,0,1,0,0,"pi sampling, derived from the incomplete factorial approach, is an effort to maximize the diversity of macromolecular crystallization conditions and to facilitate the preparation of 96-condition initial screens.the pi sampling method is derived from the incomplete factorial approach to macromolecular crystallization screen design. the resulting ‘pi screens’ have a modular distribution of a given set of up to 36 stock solutions. maximally diverse conditions can be produced by taking into account the properties of the chemicals used in the formulation and the concentrations of the corresponding solutions. the pi sampling method has been implemented in a web-based application that generates screen formulations and recipes. it is particularly adapted to screens consisting of 96 different conditions. the flexibility and efficiency of pi sampling is demonstrated by the crystallization of soluble proteins and of an integral membrane-protein sample.",the pi sampling method is derived from the incomplete factorial approach to macromolecular crystallization screen design. the resulting 'pi screens' have a modular distribution of a given set of up to 36 stock solutions. maximally diverse conditions can be produced by taking into account the properties of the chemicals used in the formulation and the concentrations of the corresponding solutions. the pi sampling method has been implemented in a web-based application that generates screen formulations and recipes. it is particularly adapted to screens consisting of 96 different conditions. the flexibility and efficiency of pi sampling is demonstrated by the crystallization of soluble proteins and of an integral membrane-protein sample.
d-67-00463.grobid-tei.xml,d-67-00463.nxml,authors,soft,1,0,0,0,gorrecpalmerlebonwarne,gorrecpalmerlebonwarne
d-67-00463.grobid-tei.xml,d-67-00463.nxml,authors,exact,1,0,0,0,gorrecpalmerlebonwarne,gorrecpalmerlebonwarne
d-67-00463.grobid-tei.xml,d-67-00463.nxml,authors,ratcliff_obershelp,1,0,0,0,gorrecpalmerlebonwarne,gorrecpalmerlebonwarne
d-67-00463.grobid-tei.xml,d-67-00463.nxml,authors,levenshtein,1,0,0,0,gorrecpalmerlebonwarne,gorrecpalmerlebonwarne
d-67-00463.grobid-tei.xml,d-67-00463.nxml,first_author,soft,1,0,0,0,gorrec,gorrec
d-67-00463.grobid-tei.xml,d-67-00463.nxml,first_author,exact,1,0,0,0,gorrec,gorrec
d-67-00463.grobid-tei.xml,d-67-00463.nxml,first_author,ratcliff_obershelp,1,0,0,0,gorrec,gorrec
d-67-00463.grobid-tei.xml,d-67-00463.nxml,first_author,levenshtein,1,0,0,0,gorrec,gorrec
d-67-00463.grobid-tei.xml,d-67-00463.nxml,keywords,soft,0,0,1,0,macromolecularcrystallizationinitialscreenformulationincompletefactorialapproachmodulardistributionmembraneproteincrystallizationgpcr,
d-67-00463.grobid-tei.xml,d-67-00463.nxml,keywords,exact,0,0,1,0,macromolecular crystallizationinitial screen formulationincomplete factorial approachmodular distributionmembrane-protein crystallizationgpcr,
d-67-00463.grobid-tei.xml,d-67-00463.nxml,keywords,ratcliff_obershelp,0,0,1,0,macromolecular crystallizationinitial screen formulationincomplete factorial approachmodular distributionmembrane-protein crystallizationgpcr,
d-67-00463.grobid-tei.xml,d-67-00463.nxml,keywords,levenshtein,0,0,1,0,macromolecular crystallizationinitial screen formulationincomplete factorial approachmodular distributionmembrane-protein crystallizationgpcr,
d-67-00463.grobid-tei.xml,d-67-00463.nxml,title,soft,0,1,0,0,pisamplingamethodicalandflexibleapproachtoinitialmacromolecularcrystallizationscreening,biologicalcrystallographypisamplingamethodicalandflexibleapproachtoinitialmacromolecularcrystallizationscreening
d-67-00463.grobid-tei.xml,d-67-00463.nxml,title,exact,0,1,0,0,pi sampling: a methodical and flexible approach to initial macromolecular crystallization screening,biological crystallography pi sampling: a methodical and flexible approach to initial macromolecular crystallization screening
d-67-00463.grobid-tei.xml,d-67-00463.nxml,title,ratcliff_obershelp,0,1,0,0,pi sampling: a methodical and flexible approach to initial macromolecular crystallization screening,biological crystallography pi sampling: a methodical and flexible approach to initial macromolecular crystallization screening
d-67-00463.grobid-tei.xml,d-67-00463.nxml,title,levenshtein,0,1,0,0,pi sampling: a methodical and flexible approach to initial macromolecular crystallization screening,biological crystallography pi sampling: a methodical and flexible approach to initial macromolecular crystallization screening
aas0055-0039.grobid-tei.xml,aas0055-0039.nxml,abstract,soft,0,0,1,0,backgroundhypophosphatemiaoccursinupto80%ofthepatientsduringcontinuousrenalreplacementtherapycrrtphosphatesupplementationistimeconsumingandthephosphatelevelmightbedangerouslylowbeforenormophosphatemiaisreestablishedthisstudyevaluatedthepossibilitytopreventhypophosphatemiaduringcrrttreatmentbyusinganewcommerciallyavailablephosphatecontainingdialysisfluidmethodsfortytwoheterogeneousintensivecareunitpatientsadmittedbetweenjanuary2007andjuly2008undergoinghemodiafiltrationweretreatedwithanewgambrodialysissolutionwith12mmphosphatephoxiliumorwithstandardmedicaltreatmenthemosolb0thepatientsweredividedintothreegroupsgroup1n=14receivingstandardmedicaltreatmentandintravenousphosphatesupplementationasrequiredgroup2n=14receivingthephosphatesolutionasdialysatesolutionandhemosolb0asreplacementsolutionandgroup3n=14receivingthephosphatecontainingsolutionasbothdialysateandreplacementsolutionsresultsstandardmedicaltreatmentresultedinhypophosphatemiain11of14ofthepatientsgroup1comparedwithfiveof14inthepatientsreceivingphosphatesolutionasthedialysatesolutionandhemosolb0asthereplacementsolutiongroup2patientstreatedwiththephosphatecontainingdialysissolutiongroup3experiencedstableserumphosphatelevelsthroughoutthestudypotassiumionizedcalciummagnesiumphpco2andbicarbonateremainedunchangedthroughoutthestudyconclusionthenewphosphatecontainingreplacementanddialysissolutionreducesthevariabilityofserumphosphatelevelsduringcrrtandeliminatestheincidenceofhypophosphatemia,
aas0055-0039.grobid-tei.xml,aas0055-0039.nxml,abstract,exact,0,0,1,0,"background hypophosphatemia occurs in up to 80% of the patients during continuous renal replacement therapy (crrt). phosphate supplementation is time-consuming and the phosphate level might be dangerously low before normophosphatemia is re-established. this study evaluated the possibility to prevent hypophosphatemia during crrt treatment by using a new commercially available phosphate-containing dialysis fluid. methods forty-two heterogeneous intensive care unit patients, admitted between january 2007 and july 2008, undergoing hemodiafiltration, were treated with a new gambro dialysis solution with 1.2 mm phosphate (phoxilium) or with standard medical treatment (hemosol b0). the patients were divided into three groups: group 1 (n=14) receiving standard medical treatment and intravenous phosphate supplementation as required, group 2 (n=14) receiving the phosphate solution as dialysate solution and hemosol b0 as replacement solution and group 3 (n=14) receiving the phosphate-containing solution as both dialysate and replacement solutions. results standard medical treatment resulted in hypophosphatemia in 11 of 14 of the patients (group 1) compared with five of 14 in the patients receiving phosphate solution as the dialysate solution and hemosol b0 as the replacement solution (group 2). patients treated with the phosphate-containing dialysis solution (group 3) experienced stable serum phosphate levels throughout the study. potassium, ionized calcium, magnesium, ph, pco2 and bicarbonate remained unchanged throughout the study. conclusion the new phosphate-containing replacement and dialysis solution reduces the variability of serum phosphate levels during crrt and eliminates the incidence of hypophosphatemia.",
aas0055-0039.grobid-tei.xml,aas0055-0039.nxml,abstract,ratcliff_obershelp,0,0,1,0,"background hypophosphatemia occurs in up to 80% of the patients during continuous renal replacement therapy (crrt). phosphate supplementation is time-consuming and the phosphate level might be dangerously low before normophosphatemia is re-established. this study evaluated the possibility to prevent hypophosphatemia during crrt treatment by using a new commercially available phosphate-containing dialysis fluid. methods forty-two heterogeneous intensive care unit patients, admitted between january 2007 and july 2008, undergoing hemodiafiltration, were treated with a new gambro dialysis solution with 1.2 mm phosphate (phoxilium) or with standard medical treatment (hemosol b0). the patients were divided into three groups: group 1 (n=14) receiving standard medical treatment and intravenous phosphate supplementation as required, group 2 (n=14) receiving the phosphate solution as dialysate solution and hemosol b0 as replacement solution and group 3 (n=14) receiving the phosphate-containing solution as both dialysate and replacement solutions. results standard medical treatment resulted in hypophosphatemia in 11 of 14 of the patients (group 1) compared with five of 14 in the patients receiving phosphate solution as the dialysate solution and hemosol b0 as the replacement solution (group 2). patients treated with the phosphate-containing dialysis solution (group 3) experienced stable serum phosphate levels throughout the study. potassium, ionized calcium, magnesium, ph, pco2 and bicarbonate remained unchanged throughout the study. conclusion the new phosphate-containing replacement and dialysis solution reduces the variability of serum phosphate levels during crrt and eliminates the incidence of hypophosphatemia.",
aas0055-0039.grobid-tei.xml,aas0055-0039.nxml,abstract,levenshtein,0,0,1,0,"background hypophosphatemia occurs in up to 80% of the patients during continuous renal replacement therapy (crrt). phosphate supplementation is time-consuming and the phosphate level might be dangerously low before normophosphatemia is re-established. this study evaluated the possibility to prevent hypophosphatemia during crrt treatment by using a new commercially available phosphate-containing dialysis fluid. methods forty-two heterogeneous intensive care unit patients, admitted between january 2007 and july 2008, undergoing hemodiafiltration, were treated with a new gambro dialysis solution with 1.2 mm phosphate (phoxilium) or with standard medical treatment (hemosol b0). the patients were divided into three groups: group 1 (n=14) receiving standard medical treatment and intravenous phosphate supplementation as required, group 2 (n=14) receiving the phosphate solution as dialysate solution and hemosol b0 as replacement solution and group 3 (n=14) receiving the phosphate-containing solution as both dialysate and replacement solutions. results standard medical treatment resulted in hypophosphatemia in 11 of 14 of the patients (group 1) compared with five of 14 in the patients receiving phosphate solution as the dialysate solution and hemosol b0 as the replacement solution (group 2). patients treated with the phosphate-containing dialysis solution (group 3) experienced stable serum phosphate levels throughout the study. potassium, ionized calcium, magnesium, ph, pco2 and bicarbonate remained unchanged throughout the study. conclusion the new phosphate-containing replacement and dialysis solution reduces the variability of serum phosphate levels during crrt and eliminates the incidence of hypophosphatemia.",
aas0055-0039.grobid-tei.xml,aas0055-0039.nxml,authors,soft,1,0,0,0,bromancarlssonfribergwieslandergodaly,bromancarlssonfribergwieslandergodaly
aas0055-0039.grobid-tei.xml,aas0055-0039.nxml,authors,exact,1,0,0,0,bromancarlssonfribergwieslandergodaly,bromancarlssonfribergwieslandergodaly
aas0055-0039.grobid-tei.xml,aas0055-0039.nxml,authors,ratcliff_obershelp,1,0,0,0,bromancarlssonfribergwieslandergodaly,bromancarlssonfribergwieslandergodaly
aas0055-0039.grobid-tei.xml,aas0055-0039.nxml,authors,levenshtein,1,0,0,0,bromancarlssonfribergwieslandergodaly,bromancarlssonfribergwieslandergodaly
aas0055-0039.grobid-tei.xml,aas0055-0039.nxml,first_author,soft,1,0,0,0,broman,broman
aas0055-0039.grobid-tei.xml,aas0055-0039.nxml,first_author,exact,1,0,0,0,broman,broman
aas0055-0039.grobid-tei.xml,aas0055-0039.nxml,first_author,ratcliff_obershelp,1,0,0,0,broman,broman
aas0055-0039.grobid-tei.xml,aas0055-0039.nxml,first_author,levenshtein,1,0,0,0,broman,broman
aas0055-0039.grobid-tei.xml,aas0055-0039.nxml,keywords,soft,0,0,0,1,,
aas0055-0039.grobid-tei.xml,aas0055-0039.nxml,keywords,exact,0,0,0,1,,
aas0055-0039.grobid-tei.xml,aas0055-0039.nxml,keywords,ratcliff_obershelp,0,0,0,1,,
aas0055-0039.grobid-tei.xml,aas0055-0039.nxml,keywords,levenshtein,0,0,0,1,,
aas0055-0039.grobid-tei.xml,aas0055-0039.nxml,title,soft,1,0,0,0,phosphatecontainingdialysissolutionpreventshypophosphatemiaduringcontinuousrenalreplacementtherapy,phosphatecontainingdialysissolutionpreventshypophosphatemiaduringcontinuousrenalreplacementtherapy
aas0055-0039.grobid-tei.xml,aas0055-0039.nxml,title,exact,1,0,0,0,phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy,phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy
aas0055-0039.grobid-tei.xml,aas0055-0039.nxml,title,ratcliff_obershelp,1,0,0,0,phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy,phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy
aas0055-0039.grobid-tei.xml,aas0055-0039.nxml,title,levenshtein,1,0,0,0,phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy,phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy
apha0202-0379.grobid-tei.xml,apha0202-0379.nxml,abstract,soft,1,0,0,0,thisisaninformalpersonalreviewofthedevelopmentovertimeofmyideasabouttheconcentratingmechanismofthemammalianrenalpapillaithadbeenobservedthatanimalswithaneedtoproduceaconcentratedurinehavealongrenalpapillaisawthefunctionofthelongpapillaindesertrodentsasanelongationofthecountercurrentconcentratingmechanismoftheinnermedullathismodelledmetooverlookcontraryevidenceforexampleinmanyexperimentsthefinalurinehasahigherosmolalitythanthatofthetissueatthetipofthepapillainadditionwehadobservationsoftheperistalsisoftherenalpelvissurroundingthepapillatheurineconcentrationfallsiftheperistalsisisstoppediwaswrongtogethertheselinesofevidenceshowthattherenalpapillaisnotjustanelongationoftheinnermedullaweareleftwithoutafullexplanationoftheconcentratingmechanismofthemammalianrenalpapillaitishopedthatotherresearcherswilltacklethisinterestingproblem,thisisaninformalpersonalreviewofthedevelopmentovertimeofmyideasabouttheconcentratingmechanismofthemammalianrenalpapillaithadbeenobservedthatanimalswithaneedtoproduceaconcentratedurinehavealongrenalpapillaisawthefunctionofthelongpapillaindesertrodentsasanelongationofthecountercurrentconcentratingmechanismoftheinnermedullathismodelledmetooverlookcontraryevidenceforexampleinmanyexperimentsthefinalurinehasahigherosmolalitythanthatofthetissueatthetipofthepapillainadditionwehadobservationsoftheperistalsisoftherenalpelvissurroundingthepapillatheurineconcentrationfallsiftheperistalsisisstoppediwaswrongtogethertheselinesofevidenceshowthattherenalpapillaisnotjustanelongationoftheinnermedullaweareleftwithoutafullexplanationoftheconcentratingmechanismofthemammalianrenalpapillaitishopedthatotherresearcherswilltacklethisinterestingproblem
apha0202-0379.grobid-tei.xml,apha0202-0379.nxml,abstract,exact,1,0,0,0,"this is an informal personal review of the development over time of my ideas about the concentrating mechanism of the mammalian renal papilla. it had been observed that animals with a need to produce a concentrated urine have a long renal papilla. i saw the function of the long papilla in desert rodents as an elongation of the counter-current concentrating mechanism of the inner medulla. this model led me to overlook contrary evidence. for example, in many experiments, the final urine has a higher osmolality than that of the tissue at the tip of the papilla. in addition, we had observations of the peristalsis of the renal pelvis surrounding the papilla. the urine concentration falls if the peristalsis is stopped. i was wrong; together, these lines of evidence show that the renal papilla is not just an elongation of the inner medulla. we are left without a full explanation of the concentrating mechanism of the mammalian renal papilla. it is hoped that other researchers will tackle this interesting problem.","this is an informal personal review of the development over time of my ideas about the concentrating mechanism of the mammalian renal papilla. it had been observed that animals with a need to produce a concentrated urine have a long renal papilla. i saw the function of the long papilla in desert rodents as an elongation of the counter-current concentrating mechanism of the inner medulla. this model led me to overlook contrary evidence. for example, in many experiments, the final urine has a higher osmolality than that of the tissue at the tip of the papilla. in addition, we had observations of the peristalsis of the renal pelvis surrounding the papilla. the urine concentration falls if the peristalsis is stopped. i was wrong; together, these lines of evidence show that the renal papilla is not just an elongation of the inner medulla. we are left without a full explanation of the concentrating mechanism of the mammalian renal papilla. it is hoped that other researchers will tackle this interesting problem."
apha0202-0379.grobid-tei.xml,apha0202-0379.nxml,abstract,ratcliff_obershelp,1,0,0,0,"this is an informal personal review of the development over time of my ideas about the concentrating mechanism of the mammalian renal papilla. it had been observed that animals with a need to produce a concentrated urine have a long renal papilla. i saw the function of the long papilla in desert rodents as an elongation of the counter-current concentrating mechanism of the inner medulla. this model led me to overlook contrary evidence. for example, in many experiments, the final urine has a higher osmolality than that of the tissue at the tip of the papilla. in addition, we had observations of the peristalsis of the renal pelvis surrounding the papilla. the urine concentration falls if the peristalsis is stopped. i was wrong; together, these lines of evidence show that the renal papilla is not just an elongation of the inner medulla. we are left without a full explanation of the concentrating mechanism of the mammalian renal papilla. it is hoped that other researchers will tackle this interesting problem.","this is an informal personal review of the development over time of my ideas about the concentrating mechanism of the mammalian renal papilla. it had been observed that animals with a need to produce a concentrated urine have a long renal papilla. i saw the function of the long papilla in desert rodents as an elongation of the counter-current concentrating mechanism of the inner medulla. this model led me to overlook contrary evidence. for example, in many experiments, the final urine has a higher osmolality than that of the tissue at the tip of the papilla. in addition, we had observations of the peristalsis of the renal pelvis surrounding the papilla. the urine concentration falls if the peristalsis is stopped. i was wrong; together, these lines of evidence show that the renal papilla is not just an elongation of the inner medulla. we are left without a full explanation of the concentrating mechanism of the mammalian renal papilla. it is hoped that other researchers will tackle this interesting problem."
apha0202-0379.grobid-tei.xml,apha0202-0379.nxml,abstract,levenshtein,1,0,0,0,"this is an informal personal review of the development over time of my ideas about the concentrating mechanism of the mammalian renal papilla. it had been observed that animals with a need to produce a concentrated urine have a long renal papilla. i saw the function of the long papilla in desert rodents as an elongation of the counter-current concentrating mechanism of the inner medulla. this model led me to overlook contrary evidence. for example, in many experiments, the final urine has a higher osmolality than that of the tissue at the tip of the papilla. in addition, we had observations of the peristalsis of the renal pelvis surrounding the papilla. the urine concentration falls if the peristalsis is stopped. i was wrong; together, these lines of evidence show that the renal papilla is not just an elongation of the inner medulla. we are left without a full explanation of the concentrating mechanism of the mammalian renal papilla. it is hoped that other researchers will tackle this interesting problem.","this is an informal personal review of the development over time of my ideas about the concentrating mechanism of the mammalian renal papilla. it had been observed that animals with a need to produce a concentrated urine have a long renal papilla. i saw the function of the long papilla in desert rodents as an elongation of the counter-current concentrating mechanism of the inner medulla. this model led me to overlook contrary evidence. for example, in many experiments, the final urine has a higher osmolality than that of the tissue at the tip of the papilla. in addition, we had observations of the peristalsis of the renal pelvis surrounding the papilla. the urine concentration falls if the peristalsis is stopped. i was wrong; together, these lines of evidence show that the renal papilla is not just an elongation of the inner medulla. we are left without a full explanation of the concentrating mechanism of the mammalian renal papilla. it is hoped that other researchers will tackle this interesting problem."
apha0202-0379.grobid-tei.xml,apha0202-0379.nxml,authors,soft,1,0,0,0,schmidtnielsenschmidtnielsen,schmidtnielsenschmidtnielsen
apha0202-0379.grobid-tei.xml,apha0202-0379.nxml,authors,exact,1,0,0,0,schmidt-nielsenschmidt-nielsen,schmidt-nielsenschmidt-nielsen
apha0202-0379.grobid-tei.xml,apha0202-0379.nxml,authors,ratcliff_obershelp,1,0,0,0,schmidt-nielsenschmidt-nielsen,schmidt-nielsenschmidt-nielsen
apha0202-0379.grobid-tei.xml,apha0202-0379.nxml,authors,levenshtein,1,0,0,0,schmidt-nielsenschmidt-nielsen,schmidt-nielsenschmidt-nielsen
apha0202-0379.grobid-tei.xml,apha0202-0379.nxml,first_author,soft,1,0,0,0,schmidtnielsen,schmidtnielsen
apha0202-0379.grobid-tei.xml,apha0202-0379.nxml,first_author,exact,1,0,0,0,schmidt-nielsen,schmidt-nielsen
apha0202-0379.grobid-tei.xml,apha0202-0379.nxml,first_author,ratcliff_obershelp,1,0,0,0,schmidt-nielsen,schmidt-nielsen
apha0202-0379.grobid-tei.xml,apha0202-0379.nxml,first_author,levenshtein,1,0,0,0,schmidt-nielsen,schmidt-nielsen
apha0202-0379.grobid-tei.xml,apha0202-0379.nxml,keywords,soft,1,0,0,0,concentratingmechanismkidneyperistalsisrenalpapillarenalpelviswaterremoval,concentratingmechanismkidneyperistalsisrenalpapillarenalpelviswaterremoval
apha0202-0379.grobid-tei.xml,apha0202-0379.nxml,keywords,exact,1,0,0,0,concentrating mechanismkidneyperistalsisrenal papillarenal pelviswater removal,concentrating mechanismkidneyperistalsisrenal papillarenal pelviswater removal
apha0202-0379.grobid-tei.xml,apha0202-0379.nxml,keywords,ratcliff_obershelp,1,0,0,0,concentrating mechanismkidneyperistalsisrenal papillarenal pelviswater removal,concentrating mechanismkidneyperistalsisrenal papillarenal pelviswater removal
apha0202-0379.grobid-tei.xml,apha0202-0379.nxml,keywords,levenshtein,1,0,0,0,concentrating mechanismkidneyperistalsisrenal papillarenal pelviswater removal,concentrating mechanismkidneyperistalsisrenal papillarenal pelviswater removal
apha0202-0379.grobid-tei.xml,apha0202-0379.nxml,title,soft,1,0,0,0,onthefunctionofthemammalianrenalpapillaandtheperistalsisofthesurroundingpelvis,onthefunctionofthemammalianrenalpapillaandtheperistalsisofthesurroundingpelvis
apha0202-0379.grobid-tei.xml,apha0202-0379.nxml,title,exact,1,0,0,0,on the function of the mammalian renal papilla and the peristalsis of the surrounding pelvis,on the function of the mammalian renal papilla and the peristalsis of the surrounding pelvis
apha0202-0379.grobid-tei.xml,apha0202-0379.nxml,title,ratcliff_obershelp,1,0,0,0,on the function of the mammalian renal papilla and the peristalsis of the surrounding pelvis,on the function of the mammalian renal papilla and the peristalsis of the surrounding pelvis
apha0202-0379.grobid-tei.xml,apha0202-0379.nxml,title,levenshtein,1,0,0,0,on the function of the mammalian renal papilla and the peristalsis of the surrounding pelvis,on the function of the mammalian renal papilla and the peristalsis of the surrounding pelvis
e-67-o1363.grobid-tei.xml,e-67-o1363.nxml,abstract,soft,0,1,0,0,themol­ecularstructureofthetitlecompoundc28h20n4o6consistsofthreefusedsixmemberedringsabcandonefivememberedringdthelatterislinkedtoanisoxazoleringeviaamethyl­eneunita4nitrophenylsubstituentfisattachedtotheisoxazolethefusedfiveandsixmemberedringscdarealmostcoplanarwithanrmsdeviationof00345 åandmakeadihedralangleof940 8°withringatheisoxazoleand4nitrophenylringsefarealsoalmostcoplanarwiththeimidazoleandthefusedadjacentringcdformingadihedralangleof114 6°thecrystalpackingdisplaysinter­molecularc—h⋯ohydrogenbondinganintra­molecularc—h⋯ointer­actionalsooccurs,keyindicatorssinglecrystalxraystudyt=296kmeancc=0003a˚rfactor=0040wrfactor=0111datatoparameterratio=141themolecularstructureofthetitlecompoundc28h20n4o6consistsofthreefusedsixmemberedringsabcandonefivememberedringdthelatterislinkedtoanisoxazoleringeviaamethyleneunita4nitrophenylsubstituentfisattachedtotheisoxazolethefusedfiveandsixmemberedringscdarealmostcoplanarwithanrmsdeviationof00345a˚andmakeadihedralangleof9408withringatheisoxazoleand4nitrophenylringsefarealsoalmostcoplanarwiththeimidazoleandthefusedadjacentringcdformingadihedralangleof1146thecrystalpackingdisplaysintermolecularcháááohydrogenbondinganintramolecularcháááointeractionalsooccurs
e-67-o1363.grobid-tei.xml,e-67-o1363.nxml,abstract,exact,0,1,0,0,"the mol­ecular structure of the title compound, c28h20n4o6, consists of three fused six-membered rings (a,b,c) and one five-membered ring (d). the latter is linked to an isoxazole ring (e) via a methyl­ene unit. a 4-nitro-phenyl substituent (f) is attached to the isoxazole. the fused five and six-membered rings (c,d) are almost coplanar with an r.m.s. deviation of 0.0345 å and make a dihedral angle of 9.40 (8)° with ring a. the isoxazole and 4-nitro-phenyl rings (e,f) are also almost coplanar with the imidazole and the fused adjacent ring (c,d), forming a dihedral angle of 11.4 (6)°. the crystal packing displays inter­molecular c—h⋯o hydrogen bonding. an intra­molecular c—h⋯o inter­action also occurs.","key indicators: single-crystal x-ray study; t = 296 k; mean (c-c) = 0.003 a ˚ ; r factor = 0.040; wr factor = 0.111; data-to-parameter ratio = 14.1. the molecular structure of the title compound, c 28 h 20 n 4 o 6 , consists of three fused six-membered rings (a,b,c) and one five-membered ring (d). the latter is linked to an isoxazole ring (e) via a methylene unit. a 4-nitro-phenyl substituent (f) is attached to the isoxazole. the fused five and six-membered rings (c,d) are almost coplanar with an r.m.s. deviation of 0.0345 a ˚ and make a dihedral angle of 9.40 (8) with ring a. the isoxazole and 4-nitro-phenyl rings (e,f) are also almost coplanar with the imidazole and the fused adjacent ring (c,d), forming a dihedral angle of 11.4 (6). the crystal packing displays intermolecular c-há á áo hydrogen bonding. an intramolecular c-há á áo interaction also occurs."
e-67-o1363.grobid-tei.xml,e-67-o1363.nxml,abstract,ratcliff_obershelp,0,1,0,0,"the mol­ecular structure of the title compound, c28h20n4o6, consists of three fused six-membered rings (a,b,c) and one five-membered ring (d). the latter is linked to an isoxazole ring (e) via a methyl­ene unit. a 4-nitro-phenyl substituent (f) is attached to the isoxazole. the fused five and six-membered rings (c,d) are almost coplanar with an r.m.s. deviation of 0.0345 å and make a dihedral angle of 9.40 (8)° with ring a. the isoxazole and 4-nitro-phenyl rings (e,f) are also almost coplanar with the imidazole and the fused adjacent ring (c,d), forming a dihedral angle of 11.4 (6)°. the crystal packing displays inter­molecular c—h⋯o hydrogen bonding. an intra­molecular c—h⋯o inter­action also occurs.","key indicators: single-crystal x-ray study; t = 296 k; mean (c-c) = 0.003 a ˚ ; r factor = 0.040; wr factor = 0.111; data-to-parameter ratio = 14.1. the molecular structure of the title compound, c 28 h 20 n 4 o 6 , consists of three fused six-membered rings (a,b,c) and one five-membered ring (d). the latter is linked to an isoxazole ring (e) via a methylene unit. a 4-nitro-phenyl substituent (f) is attached to the isoxazole. the fused five and six-membered rings (c,d) are almost coplanar with an r.m.s. deviation of 0.0345 a ˚ and make a dihedral angle of 9.40 (8) with ring a. the isoxazole and 4-nitro-phenyl rings (e,f) are also almost coplanar with the imidazole and the fused adjacent ring (c,d), forming a dihedral angle of 11.4 (6). the crystal packing displays intermolecular c-há á áo hydrogen bonding. an intramolecular c-há á áo interaction also occurs."
e-67-o1363.grobid-tei.xml,e-67-o1363.nxml,abstract,levenshtein,0,1,0,0,"the mol­ecular structure of the title compound, c28h20n4o6, consists of three fused six-membered rings (a,b,c) and one five-membered ring (d). the latter is linked to an isoxazole ring (e) via a methyl­ene unit. a 4-nitro-phenyl substituent (f) is attached to the isoxazole. the fused five and six-membered rings (c,d) are almost coplanar with an r.m.s. deviation of 0.0345 å and make a dihedral angle of 9.40 (8)° with ring a. the isoxazole and 4-nitro-phenyl rings (e,f) are also almost coplanar with the imidazole and the fused adjacent ring (c,d), forming a dihedral angle of 11.4 (6)°. the crystal packing displays inter­molecular c—h⋯o hydrogen bonding. an intra­molecular c—h⋯o inter­action also occurs.","key indicators: single-crystal x-ray study; t = 296 k; mean (c-c) = 0.003 a ˚ ; r factor = 0.040; wr factor = 0.111; data-to-parameter ratio = 14.1. the molecular structure of the title compound, c 28 h 20 n 4 o 6 , consists of three fused six-membered rings (a,b,c) and one five-membered ring (d). the latter is linked to an isoxazole ring (e) via a methylene unit. a 4-nitro-phenyl substituent (f) is attached to the isoxazole. the fused five and six-membered rings (c,d) are almost coplanar with an r.m.s. deviation of 0.0345 a ˚ and make a dihedral angle of 9.40 (8) with ring a. the isoxazole and 4-nitro-phenyl rings (e,f) are also almost coplanar with the imidazole and the fused adjacent ring (c,d), forming a dihedral angle of 11.4 (6). the crystal packing displays intermolecular c-há á áo hydrogen bonding. an intramolecular c-há á áo interaction also occurs."
e-67-o1363.grobid-tei.xml,e-67-o1363.nxml,authors,soft,0,1,0,0,afrakssouhaoudicapetrolandoelammari,afrakssouhaoudicapetrolandoammari
e-67-o1363.grobid-tei.xml,e-67-o1363.nxml,authors,exact,0,1,0,0,afrakssouhaoudicapetrolandoel ammari,afrakssouhaoudicapetrolandoammari
e-67-o1363.grobid-tei.xml,e-67-o1363.nxml,authors,ratcliff_obershelp,1,0,0,0,afrakssouhaoudicapetrolandoel ammari,afrakssouhaoudicapetrolandoammari
e-67-o1363.grobid-tei.xml,e-67-o1363.nxml,authors,levenshtein,1,0,0,0,afrakssouhaoudicapetrolandoel ammari,afrakssouhaoudicapetrolandoammari
e-67-o1363.grobid-tei.xml,e-67-o1363.nxml,first_author,soft,1,0,0,0,afrakssou,afrakssou
e-67-o1363.grobid-tei.xml,e-67-o1363.nxml,first_author,exact,1,0,0,0,afrakssou,afrakssou
e-67-o1363.grobid-tei.xml,e-67-o1363.nxml,first_author,ratcliff_obershelp,1,0,0,0,afrakssou,afrakssou
e-67-o1363.grobid-tei.xml,e-67-o1363.nxml,first_author,levenshtein,1,0,0,0,afrakssou,afrakssou
e-67-o1363.grobid-tei.xml,e-67-o1363.nxml,keywords,soft,0,0,0,1,,
e-67-o1363.grobid-tei.xml,e-67-o1363.nxml,keywords,exact,0,0,0,1,,
e-67-o1363.grobid-tei.xml,e-67-o1363.nxml,keywords,ratcliff_obershelp,0,0,0,1,,
e-67-o1363.grobid-tei.xml,e-67-o1363.nxml,keywords,levenshtein,0,0,0,1,,
e-67-o1363.grobid-tei.xml,e-67-o1363.nxml,title,soft,0,1,0,0,3allyl1{34nitro­phen­yl45dihydro13oxazol5ylmeth­yl}1hanthra12dimidazole26113htrione,e67o1363o1364actacryst
e-67-o1363.grobid-tei.xml,e-67-o1363.nxml,title,exact,0,1,0,0,"3-allyl-1-{[3-(4-nitro­phen­yl)-4,5-dihydro-1,3-oxazol-5-yl]meth­yl}-1h-anthra[1,2-d]imidazole-2,6,11(3h)-trione","e67, o1363-o1364 acta cryst"
e-67-o1363.grobid-tei.xml,e-67-o1363.nxml,title,ratcliff_obershelp,0,1,0,0,"3-allyl-1-{[3-(4-nitro­phen­yl)-4,5-dihydro-1,3-oxazol-5-yl]meth­yl}-1h-anthra[1,2-d]imidazole-2,6,11(3h)-trione","e67, o1363-o1364 acta cryst"
e-67-o1363.grobid-tei.xml,e-67-o1363.nxml,title,levenshtein,0,1,0,0,"3-allyl-1-{[3-(4-nitro­phen­yl)-4,5-dihydro-1,3-oxazol-5-yl]meth­yl}-1h-anthra[1,2-d]imidazole-2,6,11(3h)-trione","e67, o1363-o1364 acta cryst"
apa0100-0653.grobid-tei.xml,apa0100-0653.nxml,abstract,soft,0,1,0,0,aimtodeterminewhetherthesizeandshapeoftheplacentalsurfacepredictbloodpressureinchildhoodmethodswestudiedbloodpressurein471nineyearoldindianchildrenwhoseplacentallengthbreadthandweightweremeasuredinaprospectivebirthcohortstudyresultsinthedaughtersofshortmothers<medianheightsystolicbloodpressuresbproseasplacentalbreadthincreasedβ=069mmhgcmp=005andastheratioofplacentalsurfaceareatobirthweightincreasedp=00003inthedaughtersoftallmotherssbproseasthedifferencebetweenplacentallengthandbreadthincreasedβ=140mmhgcmp=0007thatisasthesurfacebecamemoreovalamongboysassociationswithplacentalsizewereonlystatisticallysignificantafteradjustingforcurrentbmiandheightafteradjustmentsbproseasplacentalbreadthareaandweightdecreasedforbreadthβ=068mmhgcmp<005forallthreemeasurementsconclusionsthesizeandshapeoftheplacentalsurfacepredictchildhoodbloodpressurebloodpressuremaybeprogrammedbyvariationinthenormalprocessesofplacentationtheseincludeimplantationexpansionofthechorionicsurfaceinmidgestationandcompensatoryexpansionofthechorionicsurfaceinlategestation,aimtodeterminewhetherthesizeandshapeoftheplacentalsurfacepredictbloodpressureinchildhoodmethodswestudiedbloodpressurein471nineyearoldindianchildrenwhoseplacentallengthbreadthandweightweremeasuredinaprospectivebirthcohortstudyresultsinthedaughtersofshortmothers<medianheightsystolicbloodpressuresbproseasplacentalbreadthincreasedb=069mmhg⁄cmp=005andastheratioofplacentalsurfaceareatobirthweightincreasedp=00003inthedaughtersoftallmotherssbproseasthedifferencebetweenplacentallengthandbreadthincreasedb=140mmhg⁄cmp=0007thatisasthesurfacebecamemoreovalamongboysassociationswithplacentalsizewereonlystatisticallysignificantafteradjustingforcurrentbmiandheightafteradjustmentsbproseasplacentalbreadthareaandweightdecreasedforbreadthb=068mmhg⁄cmp<005forallthreemeasurements
apa0100-0653.grobid-tei.xml,apa0100-0653.nxml,abstract,exact,0,1,0,0,"aim to determine whether the size and shape of the placental surface predict blood pressure in childhood. methods we studied blood pressure in 471 nine-year-old indian children whose placental length, breadth and weight were measured in a prospective birth cohort study. results in the daughters of short mothers (<median height), systolic blood pressure (sbp) rose as placental breadth increased (β = 0.69 mmhg/cm, p = 0.05) and as the ratio of placental surface area to birthweight increased (p = 0.0003). in the daughters of tall mothers, sbp rose as the difference between placental length and breadth increased (β = 1.40 mmhg/cm, p = 0.007), that is as the surface became more oval. among boys, associations with placental size were only statistically significant after adjusting for current bmi and height. after adjustment, sbp rose as placental breadth, area and weight decreased (for breadth β = −0.68 mmhg/cm, p < 0.05 for all three measurements). conclusions the size and shape of the placental surface predict childhood blood pressure. blood pressure may be programmed by variation in the normal processes of placentation: these include implantation, expansion of the chorionic surface in mid-gestation and compensatory expansion of the chorionic surface in late gestation.","aim: to determine whether the size and shape of the placental surface predict blood pressure in childhood. methods: we studied blood pressure in 471 nine-year-old indian children whose placental length, breadth and weight were measured in a prospective birth cohort study. results: in the daughters of short mothers (<median height), systolic blood pressure (sbp) rose as placental breadth increased (b = 0.69 mmhg ⁄ cm, p = 0.05) and as the ratio of placental surface area to birthweight increased (p = 0.0003). in the daughters of tall mothers, sbp rose as the difference between placental length and breadth increased (b = 1.40 mmhg ⁄ cm, p = 0.007), that is as the surface became more oval. among boys, associations with placental size were only statistically significant after adjusting for current bmi and height. after adjustment, sbp rose as placental breadth, area and weight decreased (for breadth b =)0.68 mmhg ⁄ cm, p < 0.05 for all three measurements)."
apa0100-0653.grobid-tei.xml,apa0100-0653.nxml,abstract,ratcliff_obershelp,0,1,0,0,"aim to determine whether the size and shape of the placental surface predict blood pressure in childhood. methods we studied blood pressure in 471 nine-year-old indian children whose placental length, breadth and weight were measured in a prospective birth cohort study. results in the daughters of short mothers (<median height), systolic blood pressure (sbp) rose as placental breadth increased (β = 0.69 mmhg/cm, p = 0.05) and as the ratio of placental surface area to birthweight increased (p = 0.0003). in the daughters of tall mothers, sbp rose as the difference between placental length and breadth increased (β = 1.40 mmhg/cm, p = 0.007), that is as the surface became more oval. among boys, associations with placental size were only statistically significant after adjusting for current bmi and height. after adjustment, sbp rose as placental breadth, area and weight decreased (for breadth β = −0.68 mmhg/cm, p < 0.05 for all three measurements). conclusions the size and shape of the placental surface predict childhood blood pressure. blood pressure may be programmed by variation in the normal processes of placentation: these include implantation, expansion of the chorionic surface in mid-gestation and compensatory expansion of the chorionic surface in late gestation.","aim: to determine whether the size and shape of the placental surface predict blood pressure in childhood. methods: we studied blood pressure in 471 nine-year-old indian children whose placental length, breadth and weight were measured in a prospective birth cohort study. results: in the daughters of short mothers (<median height), systolic blood pressure (sbp) rose as placental breadth increased (b = 0.69 mmhg ⁄ cm, p = 0.05) and as the ratio of placental surface area to birthweight increased (p = 0.0003). in the daughters of tall mothers, sbp rose as the difference between placental length and breadth increased (b = 1.40 mmhg ⁄ cm, p = 0.007), that is as the surface became more oval. among boys, associations with placental size were only statistically significant after adjusting for current bmi and height. after adjustment, sbp rose as placental breadth, area and weight decreased (for breadth b =)0.68 mmhg ⁄ cm, p < 0.05 for all three measurements)."
apa0100-0653.grobid-tei.xml,apa0100-0653.nxml,abstract,levenshtein,0,1,0,0,"aim to determine whether the size and shape of the placental surface predict blood pressure in childhood. methods we studied blood pressure in 471 nine-year-old indian children whose placental length, breadth and weight were measured in a prospective birth cohort study. results in the daughters of short mothers (<median height), systolic blood pressure (sbp) rose as placental breadth increased (β = 0.69 mmhg/cm, p = 0.05) and as the ratio of placental surface area to birthweight increased (p = 0.0003). in the daughters of tall mothers, sbp rose as the difference between placental length and breadth increased (β = 1.40 mmhg/cm, p = 0.007), that is as the surface became more oval. among boys, associations with placental size were only statistically significant after adjusting for current bmi and height. after adjustment, sbp rose as placental breadth, area and weight decreased (for breadth β = −0.68 mmhg/cm, p < 0.05 for all three measurements). conclusions the size and shape of the placental surface predict childhood blood pressure. blood pressure may be programmed by variation in the normal processes of placentation: these include implantation, expansion of the chorionic surface in mid-gestation and compensatory expansion of the chorionic surface in late gestation.","aim: to determine whether the size and shape of the placental surface predict blood pressure in childhood. methods: we studied blood pressure in 471 nine-year-old indian children whose placental length, breadth and weight were measured in a prospective birth cohort study. results: in the daughters of short mothers (<median height), systolic blood pressure (sbp) rose as placental breadth increased (b = 0.69 mmhg ⁄ cm, p = 0.05) and as the ratio of placental surface area to birthweight increased (p = 0.0003). in the daughters of tall mothers, sbp rose as the difference between placental length and breadth increased (b = 1.40 mmhg ⁄ cm, p = 0.007), that is as the surface became more oval. among boys, associations with placental size were only statistically significant after adjusting for current bmi and height. after adjustment, sbp rose as placental breadth, area and weight decreased (for breadth b =)0.68 mmhg ⁄ cm, p < 0.05 for all three measurements)."
apa0100-0653.grobid-tei.xml,apa0100-0653.nxml,authors,soft,0,1,0,0,winderkrishnavenihillkaratfallveenabarker,winderkrishnavenihilllskaratfallveenajpbarkercorrespondence
apa0100-0653.grobid-tei.xml,apa0100-0653.nxml,authors,exact,0,1,0,0,winderkrishnavenihillkaratfallveenabarker,winderkrishnavenihillls karatfallveenajp barkercorrespondence
apa0100-0653.grobid-tei.xml,apa0100-0653.nxml,authors,ratcliff_obershelp,0,1,0,0,winderkrishnavenihillkaratfallveenabarker,winderkrishnavenihillls karatfallveenajp barkercorrespondence
apa0100-0653.grobid-tei.xml,apa0100-0653.nxml,authors,levenshtein,0,1,0,0,winderkrishnavenihillkaratfallveenabarker,winderkrishnavenihillls karatfallveenajp barkercorrespondence
apa0100-0653.grobid-tei.xml,apa0100-0653.nxml,first_author,soft,1,0,0,0,winder,winder
apa0100-0653.grobid-tei.xml,apa0100-0653.nxml,first_author,exact,1,0,0,0,winder,winder
apa0100-0653.grobid-tei.xml,apa0100-0653.nxml,first_author,ratcliff_obershelp,1,0,0,0,winder,winder
apa0100-0653.grobid-tei.xml,apa0100-0653.nxml,first_author,levenshtein,1,0,0,0,winder,winder
apa0100-0653.grobid-tei.xml,apa0100-0653.nxml,keywords,soft,1,0,0,0,birthsizebloodpressureindianchildrenmaternalheightplacentalsurface,birthsizebloodpressureindianchildrenmaternalheightplacentalsurface
apa0100-0653.grobid-tei.xml,apa0100-0653.nxml,keywords,exact,1,0,0,0,birth sizeblood pressureindian childrenmaternal heightplacental surface,birth sizeblood pressureindian childrenmaternal heightplacental surface
apa0100-0653.grobid-tei.xml,apa0100-0653.nxml,keywords,ratcliff_obershelp,1,0,0,0,birth sizeblood pressureindian childrenmaternal heightplacental surface,birth sizeblood pressureindian childrenmaternal heightplacental surface
apa0100-0653.grobid-tei.xml,apa0100-0653.nxml,keywords,levenshtein,1,0,0,0,birth sizeblood pressureindian childrenmaternal heightplacental surface,birth sizeblood pressureindian childrenmaternal heightplacental surface
apa0100-0653.grobid-tei.xml,apa0100-0653.nxml,title,soft,1,0,0,0,placentalprogrammingofbloodpressureinindianchildren,placentalprogrammingofbloodpressureinindianchildren
apa0100-0653.grobid-tei.xml,apa0100-0653.nxml,title,exact,1,0,0,0,placental programming of blood pressure in indian children,placental programming of blood pressure in indian children
apa0100-0653.grobid-tei.xml,apa0100-0653.nxml,title,ratcliff_obershelp,1,0,0,0,placental programming of blood pressure in indian children,placental programming of blood pressure in indian children
apa0100-0653.grobid-tei.xml,apa0100-0653.nxml,title,levenshtein,1,0,0,0,placental programming of blood pressure in indian children,placental programming of blood pressure in indian children
